Ocular Therapeutix’s Eye Drug Superior to Regeneron’s Eylea in Late-stage Trial

Ocular Therapeutix said on Tuesday its experimental eye disease drug was more effective in helping patients maintain their vision ⁠compared to Regeneron's approved treatment...
Reuters Health Information